Loading...
XSTO
PREC
Market cap14mUSD
Jul 09, Last price  
1.80SEK
1D
0.00%
1Q
5.26%
Jan 2017
-94.38%
IPO
-99.13%
Name

Precise Biometrics AB

Chart & Performance

D1W1MN
XSTO:PREC chart
P/E
—
P/S
1.79
EPS
—
Div Yield, %
—
Shrs. gr., 5y
13.70%
Rev. gr., 5y
-3.37%
Revenues
78m
-10.41%
47,733,00024,815,00045,868,00068,655,00044,944,00021,615,00028,281,00034,944,00031,387,00056,337,00097,223,00061,039,00067,645,00091,927,00092,349,00083,319,00091,020,00075,069,00086,852,00077,814,000
Net income
-20m
L+136.26%
-90,875,000-35,289,000-54,180,000-21,772,000-14,648,000-33,216,000-46,952,000-43,272,000-44,045,000-9,469,00031,193,000-17,431,000-20,454,0001,021,000-12,164,000-13,446,000-22,230,000-26,403,000-8,433,000-19,924,000
CFO
2m
-80.91%
-34,091,000-36,773,000-19,833,000-21,207,000-10,138,000-36,247,000-48,603,000-34,212,000-34,496,000-4,459,00037,658,00022,788,000-26,055,000-477,00021,792,000-1,493,0003,931,000-10,760,00010,055,0001,919,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Precise Biometrics AB (publ) develops specialized software for reliably confirming individuals' identities across Europe, Asia, and the United States. Its product lineup includes Precise YOUNiQ, designed for digital identity verification; the BioMatch series, which comprises fingerprint algorithm solutions like BioMatch Card for secure authentication on smart cards and BioMatch Mobile for integration into smartphones and tablets; and Precise BioLive, a fingerprint software capable of detecting fake or spoofed fingerprints. The company's offerings are utilized by a wide range of clients, including sensor manufacturers, security companies, and system integrators, with applications spanning sectors such as finance, betting, healthcare, and transportation. Founded in 1997, Precise Biometrics AB (publ) is based in Lund, Sweden.
URL
https://precisebiometrics.com/
IPO date
Oct 03, 2000
Employees
32
Domiciled in
SE
Incorporated in
SE

Valuation

Title
SEK in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT